MMP2 and neoplasm: These findings demonstrated that MMP-2-responsive, cleavable PEGylated liposomes significantly improved PTX accumulation and release at tumor sites by dynamically modulating their stealth properties, offering a promising strategy for advancing PTX delivery in vivo.